We are live on ! Find out more
Invesco

Invesco Portfolio holdings

AUM $1.02T
1-Year Est. Return 30.18%
 

Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-1.6%
1 Year Est. Return
+30.18%
3 Year Est. Return
+96.06%
5 Year Est. Return
+126.45%
10 Year Est. Return
+482.58%
AUM
$528B
AUM Growth
-$13B
Cap. Flow
+$7.21B
Cap. Flow %
1.37%
Top 10 Hldgs %
17.15%
Holding
3,856
New
117
Increased
1,793
Reduced
1,749
Closed
89

Sector Composition

Rank Sector Weight
1 Technology 23.41%
2 Financials 13.31%
3 Industrials 11.28%
4 Healthcare 10.55%
5 Consumer Discretionary 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADAP
3676
DELISTED
Adaptimmune Therapeutics
ADAP
$15.4K ﹤0.01%
78,031
+14,696
+23% +$7.61K
NAUT icon
3677
Nautilus Biotechnolgy
NAUT
$147M
$14.7K ﹤0.01%
17,101
-780
-4% -$1.16K
HOWL icon
3678
Werewolf Therapeutics
HOWL
$22.9M
$13.8K ﹤0.01%
14,232
-357
-2% -$467
XFOR icon
3679
X4 Pharmaceuticals
XFOR
$376M
$13.8K ﹤0.01%
1,940
-129
-6% -$1.78K
FBLG icon
3680
FibroBiologics
FBLG
$3.95M
$11.4K ﹤0.01%
633
HBIO icon
3681
Harvard Bioscience
HBIO
$26.7M
$9.56K ﹤0.01%
1,690
-50
-3% -$640
SCWO icon
3682
374Water
SCWO
$39M
$9.17K ﹤0.01%
2,697
OVID icon
3683
Ovid Therapeutics
OVID
$427M
$8.49K ﹤0.01%
27,207
AMRN
3684
Amarin Corp
AMRN
$299M
$7.5K ﹤0.01%
837
-1
-0.1% -$11
MKTW icon
3685
MarketWise
MKTW
$53.9M
$6.96K ﹤0.01%
705
+26
+4% +$311
TNYA icon
3686
Tenaya Therapeutics
TNYA
$159M
$6.96K ﹤0.01%
12,209
-667
-5% -$658
ELEV
3687
DELISTED
Elevation Oncology
ELEV
$6.51K ﹤0.01%
25,113
+318
+1% +$182
GBIO
3688
DELISTED
Generation Bio
GBIO
$5.48K ﹤0.01%
1,354
-82
-6% -$576
SCLX icon
3689
Scilex Holding
SCLX
$48.2M
$5.13K ﹤0.01%
590
+52
+10% +$653
SST icon
3690
System1
SST
$15M
$4.26K ﹤0.01%
1,117
LYRA
3691
DELISTED
LYRA THERAPEUTICS INC
LYRA
$2.98K ﹤0.01%
473
BALY icon
3692
Bally's
BALY
$717M
-141,584
Closed -$2.53M
BATRA icon
3693
Atlanta Braves Holdings Series A
BATRA
$3.51B
-8,262
Closed -$337K
BBAR icon
3694
BBVA Argentina
BBAR
$3.81B
-58,913
Closed -$1.12M
BH icon
3695
Biglari Holdings Class B
BH
$1.23B
-15,805
Closed -$4.02M
BPT
3696
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
-127,664
Closed -$69.4K
BSVN icon
3697
Bank7 Corp
BSVN
$481M
-91,972
Closed -$4.29M
BTA
3698
DELISTED
BlackRock Long-Term Municipal Advantage Trust
BTA
-38,760
Closed -$378K
BTCS icon
3699
BTCS Inc
BTCS
$50.3M
-118,976
Closed -$294K
BTCT icon
3700
BTC Digital
BTCT
$9.08M
-23,728
Closed -$113K

Similar funds

Invesco's Q1 2025 Portfolio in Review

As of Q1 2025, Invesco held 3,856 positions worth $528B, down 2.4% from $541B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Invesco's Q1 2025 filing shows 117 new, 1,793 increased, 1,749 reduced and 89 closed positions. Its largest new stake was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M. The largest sale was Invesco S&P 500 Pure Value ETF, an estimated $491M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.

  • Invesco's largest Q1 2025 buy was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M.
  • Invesco added most to Tesla in Q1 2025, an estimated $737M increase.
  • Invesco's biggest Q1 2025 reduction was Invesco S&P 500 Pure Value ETF, cutting an estimated $491M.
  • Invesco fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $281M.
  • Invesco's ten largest holdings make up 17% of its $528B portfolio in Q1 2025.
  • Invesco opened 117 new positions and closed 89 in Q1 2025.
  • Invesco's portfolio value fell 2.4% quarter-over-quarter to $528B.

Based on Invesco's 13F filing for Q1 2025, filed 12 May 2025.